This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.
We’ve been asked by CADTH* to do a Patient Group Review of the new INTERFERON-FREE drug combo sofosbuvir and ledipasvir (also known as SOVALDI and GS-5885) for Chronic Hepatitis C, developed by Gilead Sciences. We urgently request input from individual HCV+ people (both those who have and have not tried this drug combination, any genotype).
-
For background info see http://hepcbc.bchep.org/contribute-sofosbuvir-ledipasvir-submission-cadth/.
-
For the actual questionnaire, go to: http://hepcbc.bchep.org/questions-cadth-sofosbuvir-ledipasvir/. DEADLINE: Sunday, October 5th, 2014.
-
Please tweet, re-tweet, put on Facebook, and forward this information, thanks!
*CADTH = Canadian Agency for Drugs and Technologies in Health, which does government-requested reviews for Health Canada and the Canadian Drug Review process.